Filed: 5/15/2026ACC: 0001420506-26-001039
📋 What this filing means
CALIGAN PARTNERS LP filed this quarterly 13F‑HR report disclosing 26 equity positions with a total reported market value of $1.50B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
26
Positions
$1.50B
Total AUM (reported)
58.16M
Total Shares
Allocation by class
COM$828.91M55.2%
COM NEW$443.94M29.5%
SPONSORED ADS$162.79M10.8%
COM SHS$39.52M2.6%
ADS$27.61M1.8%
Portfolio Concentration
Top 3$652.19M43.4%
4–10$502.70M33.5%
11–25$346.94M23.1%
Rest$943.0K0.1%
Top 3 weight
43.4%
Top 10 weight
76.9%
Voting Authority Distribution
Total shares with voting rights: 58.16M
Sole
Full voting authority
58.16M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole26
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings26
Rows:
LIQUIDIA CORPORATION
SOLEShares8.12M
TypeSH
Market value$306.41M
20.39%
Sole
8.12M
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares1.88M
TypeSH
Market value$183.00M
12.18%
Sole
1.88M
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares1.46M
TypeSH
Market value$162.79M
10.83%
Sole
1.46M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares2.06M
TypeSH
Market value$119.75M
7.97%
Sole
2.06M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares1.39M
TypeSH
Market value$81.00M
5.39%
Sole
1.39M
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares2.77M
TypeSH
Market value$75.11M
5.00%
Sole
2.77M
Shared
0.00
None
0.00
EXELIXIS INC
SOLEShares1.55M
TypeSH
Market value$66.62M
4.43%
Sole
1.55M
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares900K
TypeSH
Market value$60.91M
4.05%
Sole
900K
Shared
0.00
None
0.00
TANGO THERAPEUTICS INC
SOLEShares2.41M
TypeSH
Market value$50.39M
3.35%
Sole
2.41M
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares1.28M
TypeSH
Market value$48.91M
3.25%
Sole
1.28M
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares5.06M
TypeSH
Market value$45.56M
3.03%
Sole
5.06M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares878.13K
TypeSH
Market value$44.29M
2.95%
Sole
878.13K
Shared
0.00
None
0.00
LB PHARMACEUTICALS INC
SOLEShares1.44M
TypeSH
Market value$34.63M
2.30%
Sole
1.44M
Shared
0.00
None
0.00
VOR BIOPHARMA INC
SOLEShares1.93M
TypeSH
Market value$34.34M
2.29%
Sole
1.93M
Shared
0.00
None
0.00
SAB BIOTHERAPEUTICS INC
SOLEShares7.97M
TypeSH
Market value$30.51M
2.03%
Sole
7.97M
Shared
0.00
None
0.00
OPUS GENETICS INC
SOLEShares6.08M
TypeSH
Market value$27.64M
1.84%
Sole
6.08M
Shared
0.00
None
0.00
INVENTIVA SA
SOLEShares4.97M
TypeSH
Market value$27.61M
1.84%
Sole
4.97M
Shared
0.00
None
0.00
MBX BIOSCIENCES INC
SOLEShares848.59K
TypeSH
Market value$25.33M
1.69%
Sole
848.59K
Shared
0.00
None
0.00
AVALO THERAPEUTICS INC
SOLEShares1.64M
TypeSH
Market value$24.41M
1.62%
Sole
1.64M
Shared
0.00
None
0.00
ANIKA THERAPEUTICS INC
SOLEShares1.44M
TypeSH
Market value$20.81M
1.38%
Sole
1.44M
Shared
0.00
None
0.00
MAZE THERAPEUTICS INC
SOLEShares614.96K
TypeSH
Market value$18.36M
1.22%
Sole
614.96K
Shared
0.00
None
0.00
VERRICA PHARMACEUTICALS INC
SOLEShares923.91K
TypeSH
Market value$4.89M
0.33%
Sole
923.91K
Shared
0.00
None
0.00
SENSEI BIOTHERAPEUTICS INC
SOLEShares126K
TypeSH
Market value$3.97M
0.26%
Sole
126K
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS INC
SOLEShares90K
TypeSH
Market value$3.04M
0.20%
Sole
90K
Shared
0.00
None
0.00
AURA BIOSCIENCES INC
SOLEShares229.86K
TypeSH
Market value$1.54M
0.10%
Sole
229.86K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
LIQUIDIA CORPORATIONSOLE | COM NEW | 8.12M | SH | $306.41M 20.39% | 8.12M | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 1.88M | SH | $183.00M 12.18% | 1.88M | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 1.46M | SH | $162.79M 10.83% | 1.46M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 2.06M | SH | $119.75M 7.97% | 2.06M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 1.39M | SH | $81.00M 5.39% | 1.39M | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 2.77M | SH | $75.11M 5.00% | 2.77M | 0.00 | 0.00 |
EXELIXIS INCSOLE | COM | 1.55M | SH | $66.62M 4.43% | 1.55M | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 900K | SH | $60.91M 4.05% | 900K | 0.00 | 0.00 |
TANGO THERAPEUTICS INCSOLE | COM | 2.41M | SH | $50.39M 3.35% | 2.41M | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COM | 1.28M | SH | $48.91M 3.25% | 1.28M | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | COM | 5.06M | SH | $45.56M 3.03% | 5.06M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 878.13K | SH | $44.29M 2.95% | 878.13K | 0.00 | 0.00 |
LB PHARMACEUTICALS INCSOLE | COM SHS | 1.44M | SH | $34.63M 2.30% | 1.44M | 0.00 | 0.00 |
VOR BIOPHARMA INCSOLE | COM NEW | 1.93M | SH | $34.34M 2.29% | 1.93M | 0.00 | 0.00 |
SAB BIOTHERAPEUTICS INCSOLE | COM NEW | 7.97M | SH | $30.51M 2.03% | 7.97M | 0.00 | 0.00 |
OPUS GENETICS INCSOLE | COM | 6.08M | SH | $27.64M 1.84% | 6.08M | 0.00 | 0.00 |
INVENTIVA SASOLE | ADS | 4.97M | SH | $27.61M 1.84% | 4.97M | 0.00 | 0.00 |
MBX BIOSCIENCES INCSOLE | COM | 848.59K | SH | $25.33M 1.69% | 848.59K | 0.00 | 0.00 |
AVALO THERAPEUTICS INCSOLE | COM NEW | 1.64M | SH | $24.41M 1.62% | 1.64M | 0.00 | 0.00 |
ANIKA THERAPEUTICS INCSOLE | COM | 1.44M | SH | $20.81M 1.38% | 1.44M | 0.00 | 0.00 |
MAZE THERAPEUTICS INCSOLE | COM | 614.96K | SH | $18.36M 1.22% | 614.96K | 0.00 | 0.00 |
VERRICA PHARMACEUTICALS INCSOLE | COM SHS | 923.91K | SH | $4.89M 0.33% | 923.91K | 0.00 | 0.00 |
SENSEI BIOTHERAPEUTICS INCSOLE | COM NEW | 126K | SH | $3.97M 0.26% | 126K | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS INCSOLE | COM | 90K | SH | $3.04M 0.20% | 90K | 0.00 | 0.00 |
AURA BIOSCIENCES INCSOLE | COM | 229.86K | SH | $1.54M 0.10% | 229.86K | 0.00 | 0.00 |
Page 1 of 2